SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccesso Technology Group Regulatory News (ACSO)

Share Price Information for Accesso Technology Group (ACSO)

Share Price is delayed by 15 minutes
Get Live Data
327.00    -1.00 (-0.30%)
Bid:
326.50
Ask:
327.50
Spread: 1.00 (0.306%)
Market Cap: £105.92m
ACSO Live PriceLast checked at - London Stock Exchange

Intraday Accesso Technology Group Share Chart

Director/PDMR Shareholding

12 Jun 2020 13:02

RNS Number : 8518P
Accesso Technology Group PLC
12 June 2020
 

 

 

12 June 2020

accesso® Technology Group plc

(the "Company")

Director / PDMR Dealing Notification

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Persons Closely Associated with them

1.

Details of PDMR

a)

Name

1. Fern MacDonald

2. David Gammon

3. Karen Slatford

4. Andy Malpass

5. Bill Russell

2.

Reason for the notification

a)

Position / status

1. Chief Financial Officer

2. Non-Executive Director

3. Non-Executive Director

4. Non-Executive Director

5. Non-Executive Director

b)

Initial notification / amendment

Initial notification in each case

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

ACCESSO TECHNOLOGY GROUP PLC

b)

LEI

213800VY7MXUO7STIN73

4.

Details of the transaction(s)

a)

Description of the financial instrument

Identification Code

Ordinary Shares of accesso Technology Group plc (the 'Company') of 1 pence each 

 

ISIN: GB0001771426

 

b)

Nature of the transaction

The Company announced on 9 June 2020 that it raised gross proceeds of approximately £39.1 million through a Placing, Subscription and Open Offer. 13,481,744 new Ordinary Shares were admitted to trading on AIM on 10 June 2020. The Company's issued ordinary share capital now comprises 41,186,708 Ordinary Shares.

 

Director

Interest in shares prior to acquisition

Number of shares acquired

Total shares held beneficially on admission

% of issued share capital held

Fern

MacDonald

 

5,500

6,445

11,945

0.03%

David Gammon

 

48,000

38,483

86,483

0.21%

Karen Slatford

 

11,835

4,714

16,549

0.04%

 

Andy Malpass

 

4,352

1,062

5,414

0.01%

Bill Russell

 

30,000

2,307

32,307

0.08%

c)

Currency

GBP - British Pound

d)

Price(s) and volume(s)

Price(s)

Volume(s)

1. 290 pence

6,445

2. 290 pence

38,483

3. 290 pence

4,714

4. 290 pence

1,062

5. 290 pence

2,307

e)

Aggregated information

 

Aggregated volume

 

Price

 

 

53,011 shares

 

290 pence

 

f)

Date of the transaction

10 June 2020

g)

Place of the transaction

London Stock Exchange

 

 

For further information, please contact:

accesso Technology Group plc

+44 (0)118 934 7400

Steve Brown, Chief Executive Officer

Fern MacDonald, Chief Financial Officer

Numis Securities Limited (Nominated Adviser and Sole Broker)

+44 (0)20 7260 1000

Simon Willis, Mark Lander, Hugo Rubinstein

FTI Consulting, LLP (Financial Public Relations)

+44 (0)20 3727 1000

Matt Dixon, Adam Davidson, Chris Birt

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFIFRIIFLII
Date   Source Headline
5th Jun 20267:00 amRNSHolding(s) in Company
28th May 20266:00 pmRNSHolding(s) in Company
28th May 20267:00 amRNSResult of AGM
18th May 20267:00 amRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSChief Executive Officer Succession
29th Apr 20267:00 amRNSAnnual Report and Notice of AGM
22nd Apr 20267:00 amRNSAppointment of Non-Executive Director
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSAcquisition of Dexibit
30th Mar 20267:00 amRNSFinal Results
20th Mar 20266:05 pmRNSHolding(s) in Company
18th Mar 20264:54 pmRNSCompletion of Tender Offer & Total Voting Rights
13th Mar 20261:34 pmRNSResult of Tender Offer
13th Mar 20261:28 pmRNSResult of General Meeting
11th Feb 20267:00 amRNSTender Offer
10th Feb 20267:00 amRNS-RExpansion of Strategic Partnership with Adyen
6th Feb 20263:06 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSTotal Voting Rights
29th Jan 20267:00 amRNSTrading Update and Tender Offer
9th Jan 20265:30 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTrading Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20256:02 pmRNSHolding(s) in Company
22nd Dec 20256:02 pmRNSHolding(s) in Company
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 202511:33 amRNSHolding(s) in Company
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.